Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
Apr 2010 - J. Gastroenterol.; 45(4):1435-5922 [PMID:19936602]
[Hiroishi K] [Eguchi J] [Baba T] [Shimazaki T] [Ishii S] [Hiraide A] [Sakaki M] [Doi H] [Uozumi S] [Omori R] [Matsumura T] [Yanagawa T] [Ito T] [Imawari M]

Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics.
Jan 2007 - Clin. Cancer Res.; 13(2 Pt 1):1078-0432 [PMID:17255279]
[Zhang JG] [Eguchi J] [Kruse CA] [Gomez GG] [Fakhrai H] [Schroter S] [Ma W] [Hoa N] [Minev B] [Delgado C] [Wepsic HT] [Okada H] [Jadus MR]